GYNAECOLOGICAL ONCOLOGY

Gynaecological Oncology

Gynaecological oncology is a specialized branch of medicine focused on cancers of the female reproductive system. These include malignancies of the cervix, ovary, endometrium (uterus), vulva, vagina, fallopian tubes, and gestational trophoblastic disease. The field integrates surgery, chemotherapy, radiotherapy, targeted therapy, and palliative care to provide comprehensive management. Early diagnosis, appropriate staging, and multidisciplinary care are central to improving survival and quality of life.

Major Types of Gynaecological Cancers

1. Cervical Cancer
Cervical cancer remains one of the most common cancers among women worldwide, particularly in low- and middle-income countries. Persistent infection with high-risk human papillomavirus (HPV), especially types 16 and 18, is the primary etiological factor. Risk factors include early sexual activity, multiple sexual partners, smoking, and immunosuppression. Screening through Pap smear cytology and HPV testing has significantly reduced incidence in countries with organized programs. Early-stage disease may be treated with surgery (conization, hysterectomy), while advanced stages require chemoradiation.

2. Ovarian Cancer
Ovarian cancer is the most lethal gynaecological malignancy because it is often diagnosed at an advanced stage. Epithelial ovarian cancer is the most common histological type. Risk factors include nulliparity, infertility, late menopause, and genetic mutations such as BRCA1 and BRCA2. Symptoms are often vague—abdominal bloating, pelvic pain, and early satiety—leading to delayed diagnosis. Management typically involves cytoreductive (debulking) surgery followed by platinum-based chemotherapy. Targeted therapies such as PARP inhibitors have improved outcomes in selected patients.

3. Endometrial Cancer
Endometrial carcinoma is the most common gynaecological cancer in developed countries. It is strongly associated with unopposed estrogen exposure, obesity, diabetes, hypertension, and polycystic ovarian syndrome (PCOS). Postmenopausal bleeding is the hallmark symptom and warrants prompt evaluation. Diagnosis is made by endometrial biopsy. Treatment generally consists of total hysterectomy with bilateral salpingo-oophorectomy, often combined with lymph node assessment. Prognosis is favorable when detected early.

4. Vulvar and Vaginal Cancer
These cancers are relatively rare. Vulvar cancer is often linked to HPV infection or chronic inflammatory conditions such as lichen sclerosus. Symptoms include pruritus, pain, or a vulvar lesion. Surgical excision with or without lymphadenectomy is the mainstay of treatment. Vaginal cancer is uncommon and may be primary or secondary from cervical cancer.

5. Gestational Trophoblastic Neoplasia (GTN)
GTN arises from abnormal proliferation of trophoblastic tissue following a molar pregnancy or other gestational events. It is highly sensitive to chemotherapy, and cure rates are excellent even in metastatic cases when appropriately treated.

Diagnosis and Staging

Diagnosis typically involves clinical examination, imaging studies (ultrasound, CT, MRI, PET scans), tumor markers (e.g., CA-125 for ovarian cancer), and histopathological confirmation through biopsy. Staging follows the FIGO (International Federation of Gynecology and Obstetrics) system, which determines disease extent and guides treatment decisions. Accurate staging is critical for prognosis and therapeutic planning.

Treatment Modalities

Surgery:
Surgery plays a central role in both diagnosis and treatment. Procedures may range from conservative fertility-sparing surgery in selected young patients to radical hysterectomy or extensive cytoreductive surgery.

Radiotherapy:
Radiation therapy, including external beam radiotherapy (EBRT) and brachytherapy, is particularly important in cervical and endometrial cancers. It may be used as primary treatment or adjuvant therapy.

Chemotherapy:
Chemotherapy is used in advanced or high-risk cases. Common agents include platinum compounds (cisplatin, carboplatin), paclitaxel, and doxorubicin. Combination regimens are frequently employed.

Targeted and Immunotherapy:
Advances in molecular oncology have introduced targeted therapies such as PARP inhibitors for BRCA-mutated ovarian cancer and immune checkpoint inhibitors for selected cases. These therapies aim to improve outcomes while minimizing toxicity.

Prevention and Screening

Preventive strategies are crucial in gynaecological oncology. HPV vaccination significantly reduces the risk of cervical cancer. Regular screening programs using Pap smear and HPV testing enable early detection of precancerous lesions. Lifestyle modifications, including weight control and smoking cessation, reduce risk factors for several gynaecological cancers.

Psychosocial and Fertility Considerations

A diagnosis of gynaecological cancer has profound physical and psychological effects. Concerns regarding fertility, body image, sexuality, and hormonal changes must be addressed. Fertility preservation techniques such as ovarian tissue freezing or conservative surgery may be considered in selected patients. Psychological counseling and support groups play an essential role in holistic care.

Prognosis and Follow-Up

Prognosis varies depending on cancer type, stage, histology, and patient factors. Early-stage endometrial and cervical cancers have high survival rates, whereas advanced ovarian cancer has a relatively poorer prognosis. Regular follow-up is essential to detect recurrence, manage complications, and provide survivorship care.

Conclusion

Gynaecological oncology encompasses the comprehensive management of cancers affecting the female reproductive tract. Early detection, preventive measures such as HPV vaccination, advances in surgical techniques, and the development of targeted therapies have significantly improved patient outcomes. A multidisciplinary approach that integrates medical expertise with psychosocial support ensures optimal care and enhances quality of life for women affected by these malignancies.